期刊
TUBERCULOSIS
卷 91, 期 1, 页码 65-66出版社
CHURCHILL LIVINGSTONE
DOI: 10.1016/j.tube.2010.10.001
关键词
Pulmonary; Inhalation; Respirable; Drug resistance; Granuloma
资金
- CSIR NMITLI [5/258/6]
- Indian Council of Medical Research
- CSIR
Factors that are inimical to the success of inhaled therapies for tuberculosis (TB) include: (i) lack of access of inhaled therapies to poorly-aerated areas of the tubercular lung; (ii) limited ability to penetrate biofilms formed by extracellular bacilli; (iii) selection for resistant bacilli on account of administration of low doses of anti-TB agents; (iv) induction of inflammation and/or immunopathology in the airways and lungs; and (v) anomalies in antigen processing and presentation of vaccines delivered to the lungs. Further, the claim that inhaled therapies rescue alternatively-activated macrophages may not be applicable to all individuals. Fortunately, there are ways and means to address each of the above factors. (C) 2010 Elsevier Ltd. All rights reserved.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据